COMPOSITIONS AND METHODS FOR TREATING SEXUAL DYSFUNCTION AND ENHANCING SEXUAL RESPONSE… Application EP-3833341-A4 European Patent Office 04 May 2022
Treating sexual desire disorders with flibanserin Grant US-11058683-B2 United States of America 13 Jul 2021
Use of Flibanserin in the treatment of obesity Grant US-10874668-B2 United States of America 29 Dec 2020
Treating sexual desire disorders with flibanserin Grant US-10675280-B2 United States of America 09 Jun 2020
Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction Application US-10441592-B2 United States of America 15 Oct 2019
Use of flibanserin in the treatment of obesity Grant US-10335407-B2 United States of America 02 Jul 2019
Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction Application US-10314848-B2 United States of America 11 Jun 2019
Treating sexual desire disorders with flibanserin Grant US-9782403-B2 United States of America 10 Oct 2017
Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction Application US-9737548-B2 United States of America 22 Aug 2017
Use of flibanserin in the treatment of obesity Grant US-9730927-B2 United States of America 15 Aug 2017
Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction Application US-9333203-B2 United States of America 10 May 2016
USE OF THE COMBINATION OF TESTOSTERONE AND TADALAFIL IN THE TREATMENT OF FEMALE SEXUAL… Application EA-021540-B1 Eurasian Patent Organisation 30 Jul 2015
Extended release tablet formulations of flibanserin and method for manufacturing the same Grant US-8658207-B2 United States of America 25 Feb 2014
Extended release tablet formulations of flibanserin and method for manufacturing the same Grant US-8545886-B2 United States of America 01 Oct 2013
Controlled release system and method for manufacturing the same Grant US-8512748-B2 United States of America 20 Aug 2013
Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction Application US-8227453-B2 United States of America 24 Jul 2012
Use of flibanserin in the treatment of obesity Grant US-8227476-B2 United States of America 24 Jul 2012
Treating sexual desire disorders with flibanserin Grant US-8227471-B2 United States of America 24 Jul 2012
Benzimidazolone derivatives for the treatment of premenstrual and other female sexual… Grant US-7923449-B2 United States of America 12 Apr 2011
MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN Application WO-2008147556-A2 World Intellectual Property Organisation (WIPO) 04 Dec 2008
Method of treating female hypoactive sexual desire disorder with flibanserin Grant US-7151103-B2 United States of America 19 Dec 2006